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Objective:  To  analyse  the  treatment  options  that  otorhinolaryngologists  would  consider  if faced  with
advanced  stage  laryngeal  cancer  amenable  to  total  laryngectomy  or an  organ  preservation  protocol.
Material  and  methods:  Prospective  study  conducted  in  a French  Teaching  Hospital  based  on  questionnaires
ﬁlled  in  by 163  otorhinolaryngologists  in 2012,  studying  the percentage  chance  of cure  that  they  would
be  prepared  to trade-off  to preserve  their  larynx,  deﬁning  the  additional  information  that  they  would
like  to receive  and  identifying  any  statistical  associations  between  these  parameters  and  various  medical
and socioeconomic  variables.
Results:  A  total  of  42.3%  of  otorhinolaryngologists  would  not consider  the  slightest  trade-off  to preserve
their  larynx  and  preferred  to undergo  total  laryngectomy.  In the  group  of  otorhinolaryngologists  who
would consider  a larynx  preservation  protocol  (57.6%),  the  percentage  chance  of  cure  that  they would  be
willing to trade-off  to preserve  their larynx  ranged  between  5 to  100%  (median:  15%) and  4.2% of them
were  willing  to trade-off  all chances  of cure  (100%)  to  avoid  total  laryngectomy.  The percentage  of otorhi-
nolaryngologists  who  would  not  consider  trading  off the  slightest  chance  of survival  to preserve  their
larynx  increased  from  29.3  to 49.5%  (P = 0.01)  when  they  participated  in  multidisciplinary  consultation
meetings.  In the  group  of otorhinolaryngologists  who  would  consider  a larynx  preservation  protocol,
the  median  percentage  survival  trade-off  that  they  would  consider  in  order  to  preserve  their  larynx  (i)
decreased  from  20  to 10%  (P =  0.004)  when  they  participated  in multidisciplinary  consultation  meetings
and  (ii)  increased  regularly  with  their  number  of  years  of practice  (P =  0.03)  and  their  age  (P  =  0.025).
Finally,  25.1%  of otorhinolaryngologists  wanted  to  receive  additional  information,  although  none  of the
variables  analysed  affected  this  desire  for more  information.
Conclusion:  Treatment  options  considered  by  otorhinolaryngologists  faced  with  advanced  stage  laryngeal
cancer  were  almost  equally  divided  between  total  laryngectomy  and  larynx  preservation.  Number  of years
of  practice  and  regular  participation  in  head  and  neck  cancer  multidisciplinary  consultation  meetings
were  variables  that signiﬁcantly  inﬂuenced  this  choice.
© 2014  Elsevier  Masson  SAS.  All  rights  reserved.. Introduction
Over the last 20 years, larynx preservation protocols have been
eveloped as an alternative to total laryngectomy for advanced
stage III-IV) laryngeal cancer [1–8]. These protocols “trade off”
aryngeal preservation for a possible loss of a small percentage of
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879-7296/© 2014 Elsevier Masson SAS. All rights reserved.survival. Information is central to this “trade-off” decision, both
legally [9] and in terms of the doctor-patient relationship, espe-
cially as several studies [10,11] have emphasized that laryngeal
preservation was not the main treatment objective shared by all
patients. Several studies [12–14] have highlighted not only the
importance of the information given to the patient, but also the
methodology used to provide this information. The person who
informs the patient therefore plays an essential role. The present
prospective study was  consequently designed to evaluate how
French otorhinolaryngologists in clinical practice would consider
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Table 1
Medical and socioeconomic data for 163 otorhinolaryngologists who  returned an
interpretable questionnaire.
Patients
Gender: male/female 134/29
Age  (years): median (range) 49 (26–67)
Socioeconomic data
Single: yes/no 27/136
Children: yes/no 19/144
Exclusively private practice: yes/no 28/135
Number of years in practice: median (range) 18 (1–45)
Number of patients with laryngeal cancer treated or
followed over the last 12 months: median (range)
10 (0–200)
Participation in multidisciplinary consultation meetings:
yes/no
105/58
Medical data
Smoking: yes/no 31/132
Personal history of cancer: yes/no 8/155
If  yes, head and neck cancer vs. non-head and neck
cancer
0/7
Family history of cancer: yes/no 92/71
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Table 2
Univariate analysis of the decision to consider (group A; 94 otorhinolaryngologists)
or  refuse (group B: 69 otorhinolaryngologists) a survival trade-off to preserve their
larynx.
Group A Group B P
Yes Not
Gender: male/female 79/15 55/14 0.5
Age  (years): median (range) 52 (30–67) 48 (26–66) 0.2
Socioeconomic data
Single: yes/no 19/75 8/61 0.2
Children: yes/no 88/6 63/6 0.7
Exclusively private practice: yes/no 19/75 9/60 0.9
Number of years in practice: median
(range)
20 (1–39) 15 (1–45) 0.2
Number of patients with laryngeal
cancer treated or followed over the
last twelve months: median (range)
6 (0–150) 10 (0–200) 0.1
Participation in MCM:  yes/no 53.41 52/17 0.01
Medical data
Smoking: yes/no 17/77 14/55 0.8
Personal history of cancer: yes/no 5/89 3/66 0.9If yes, head and neck cancer vs. non-head and neck
cancer
2/86
his “trade-off” if faced with advanced stage laryngeal cancer, and
hether the various medical and socioeconomic variables of these
pecialists may  inﬂuence this decision.
. Material and methods
This prospective study was based on analysis of the responses
rovided to a questionnaire ﬁlled in by 169 French otorhino-
aryngologists in clinical practice. This population represented a
ubgroup of the 1649 French otorhinolaryngologists for whom the
-mail address was available to our teaching hospital department
f otorhinolaryngology and Head and Neck Surgery and to whom
he questionnaire was sent during the months of September to
ovember 2012 (with two reminders), i.e. a response rate of 10.2%
169/1649).
The ﬁrst part of this questionnaire, presented in Table 1,
ecorded various medical and socioeconomic variables concerning
torhinolaryngologists participating in this study and the second
art of the questionnaire comprised the following three questions:
if you suffered from advanced laryngeal cancer, would you choose
to be treated by chemoradiotherapy to avoid total laryngec-
tomy and its consequences, even if this treatment decreased your
chances of cure (i.e. probability of lasting disease-free survival)
rather than total laryngectomy: yes/no?
If you answered yes, please indicate what percentage chance of
cure would you be prepared to trade off to avoid total laryngec-
tomy?
Do you need more information in order to answer questions 1
and 2 and if yes, what information?
Two questionnaires with inconsistent data (two otorhinolaryn-
ologists aged 22 and 24 years with two and six years of practice,
espectively) and four incomplete questionnaires were excluded
rom the analysis. A total of 163 interpretable questionnaires were
herefore entered into a PC database and analysed by Statview soft-
are (SAS, Berkeley, USA). The objective of this analysis was  to:
determine the percentage chance of cure that otorhinolaryngolo-
gists would consider trading off in order to preserve their larynx;
describe the additional information that otorhinolaryngologists
wished to receive;
identify any statistical associations between the percentage
chance of cure that otorhinolaryngologists were prepared toFamily history of cancer: yes/no 48/46 44/35 0.1
MCM: Multidisciplinary Consultation Meeting.
trade off in order to preserve their larynx or the additional infor-
mation that they wished to receive and socioeconomic variables
(Table 1).
Parametric Fisher t tests, nonparametric Mann-Whitney U tests
and linear regression were used with a limit of signiﬁcance of 0.05.
3. Results
Sixty-nine (42.3%) of the 163 otorhinolaryngologists would not
consider any survival trade-off in order to preserve their larynx
and preferred total laryngectomy. On univariate analysis, only one
variable signiﬁcantly inﬂuenced this decision (Table 2). The per-
centage of otorhinolaryngologists who would not consider any
survival trade-off to preserve their larynx increased from 29.3%
in the absence of regular participation in head and neck cancer
multidisciplinary consultation meetings to 49.5% when these prac-
titioners regularly attended these meetings (P = 0.01).
In the group of 94 otorhinolaryngologists (57.6%) who  would
consider a larynx preservation protocol, the survival trade-off that
they would consider in order to preserve their larynx ranged from
5 to 100% (median: 15%) and 4.2% (4/94) of these practitioners
would consider a 100% trade-off in order to preserve their larynx.
On univariate analysis, two variables signiﬁcantly inﬂuenced the
percentage chance of cure that otorhinolaryngologists were willing
to trade-off in order to preserve their larynx (Table 3). The ﬁrst vari-
able was  participation in multidisciplinary consultation meetings:
the median trade-off that otorhinolaryngologists would consider in
order to preserve their larynx ranged from 20% among practitioners
not participating in head and neck cancer multidisciplinary consul-
tation meetings to 10% among practitioners participating in these
meetings (Fig. 1, P = 0.004). The second variable was the number of
years of practice, as older otorhinolaryngologists (Fig. 2, P = 0.025)
and otorhinolaryngologists with a greater number of years of prac-
tice (Fig. 3, P = 0.03) were more likely to consider a higher survival
trade-off in order to preserve their larynx.
Additional information was  requested by 25.1% (41/163) of
otorhinolaryngologists (Table 4) before deciding on a treatment
option. None of the variables analysed signiﬁcantly inﬂuenced the
desire to receive additional information. In 8.5% of cases (14/163),
the additional information requested addressed tumour charac-
teristics that could guide the treatment decision and in 15.9% of
cases (26/163) the additional information addressed data speciﬁ-
cally related to the two  treatment options considered. Finally, 3%
O. Laccourreye et al. / European Annals of Otorhinolaryngology, Head and Neck diseases 131 (2014) 339–343 341
Table  3
Univariate analysis of the percentage survival trade-off that 94 otorhinolaryngolo-
gists would consider to preserve their larynx.
Median (range) Median (range) P
Gender: male/female 30 (5–100) 10 (5–100) 0.4
Age  (years): median (range) Linear regression 0.025
Socioeconomic data
Single: yes/no 20 (5–100) 15 (5–100) 0.3
Children: yes/no 15 (5–100) 20 (5–50) 0.6
Participation in MCM:  yes/no 10 (5–80) 20 (5–100) 0.004
Exclusively private practice:
yes/no
15 (5–100) 20 (5–100)
Number of years in practice Linear regression 0.03
Number of patients with
laryngeal cancer treated or
followed over the last twelve
months
Linear regression 0.5
Medical data
Smoking: yes/no 15 (5–100) 20 (5–100) 0.5
Personal history of cancer:
yes vs. not
10 (5–100) 20 (5–100) 0.9
Family history of cancer: yes
vs. not
12 (5–100) 20 (5–100) 0.5
MCM:  Multidisciplinary Consultation Meeting.
Fig. 1. Distribution (box and whisker plot) of the percentage survival trade-off
considered by 94 otorhinolaryngologists preferring a larynx preservation proto-
col according to regular participation (yes vs. no) in multidisciplinary consultation
meetings.
Fig. 2. Linear regression (age and percentage survival trade-off considered by
94  otorhinolaryngologists to preserve their larynx).
Fig. 3. Linear regression (number of years of practice and percentage survival trade-
off  considered by 94 otorhinolaryngologists to preserve their larynx).
Table 4
Additional information requested by 41 of the 163 otorhinolaryngologists.
Additional information requested Number
Tumour characteristics 14
Response to induction chemotherapy 8
T  stage 7
N  stage 4
Cartilage invasion 3
Vocal cord mobility 1
Treatment data 26
Expected survival according to age and/or general status 13
Treatment options if failure after chemoradiotherapy 6
Adverse effects of chemoradiotherapy 4
Possibilities of speech after total laryngectomy 3
Quality of life after chemoradiotherapy 2
Specialist opinion 2
Time for reﬂection 1
To  be discussed in the real-life situation 5
(5/163) of otorhinolaryngologists indicated that it was difﬁcult to
answer the questionnaire because they did not have advanced stage
laryngeal cancer.
4. Discussion
Several studies in the ﬁeld of oncology have illustrated the
importance attributed by the patient to the surgeon’s opinion when
two conservative and non-conservative treatment options are
available. For example, in women  with breast cancer amenable to
breast-conserving treatment or mastectomy, Smitt and Heltzel [15]
and Temple et al. [16] both emphasized that the treatment recom-
mendation proposed by the surgeon and the patient’s perception
of her chances of cure were the two main factors signiﬁcantly
inﬂuencing their treatment decision. Similarly, Molenar et al. [17]
noted that the patient’s perception of the treatment option con-
sidered by the surgeon for this type of breast cancer had a major
impact on their treatment decision. In men  with prostate cancer
amenable to conservative treatment or prostatectomy, Diefenbach
et al. [18] emphasized that the element most signiﬁcantly inﬂu-
encing the treatment decision was the surgeon’s recommendation.
Song et al. [19] reported that the surgeon’s opinion had a greater
impact on the treatment decision in younger men  and/or when
the cancer was  considered to be invasive. Finally, in 2007, in a
cohort composed of 101 patients who had participated in the ﬁrst
prospective study (RTOG 91-11) [1] devoted to laryngeal preser-
vation in advanced stage laryngeal cancer, Foote et al. [20] noted
that four variables signiﬁcantly inﬂuenced the patient’s treatment
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the reader to reassess a number of ethical issues and will help42 O. Laccourreye et al. / European Annals of Otorhinol
ecision: discussion of the various treatment options with the
urgeon, the treatment option recommended by the surgeon, the
ossibility of larynx preservation surgery and referral to a medical
ncologist [20].
The weight of the surgeon’s opinion in the classical trade-off
etween cure and a chance of organ preservation with which cancer
atients are faced led us to analyse the trade-off that otorhino-
aryngologists would consider if they were placed in a hypothetical
ituation of laryngeal cancer amenable to either a larynx preser-
ation protocol or total laryngectomy. The results of this study
ust be interpreted cautiously, as this study was  based on anal-
sis of the responses of otorhinolaryngologists not speciﬁcally
ffected by the disease studied, but simply placed in a hypothet-
cal situation of laryngeal cancer. This factor could be considered to
onstitute a major bias, which limits the scope of the conclusions.
owever, we do not share this point of view for several reasons.
lthough it has been recognized, in the ﬁeld of psycho-oncology,
hat announcement of a diagnosis of cancer induces a state of shock
hat modiﬁes the mental processes of resistance and reaction, no
tudy has evaluated the real impact of this announcement on the
hoice of treatment trading off survival versus function. It should
lso be noted that only 3% of the otorhinolaryngologists in our
tudy who returned the questionnaire considered that the fact of
ot actually having laryngeal cancer would affect their responses
Table 4).
In our study, 8.5% of the otorhinolaryngologists who returned
he questionnaire wanted to receive more information concerning
he tumour characteristics before considering their treatment deci-
ion (Table 4). This very low rate is somewhat surprising, as not all
dvanced stage laryngeal cancers are equal in terms of eligibility
or larynx preservation protocols and our questionnaire made no
ention of any of the factors in favour of a larynx preservation pro-
ocol (low T stage, N0 stage, absence of extension beyond the larynx,
xtensive cartilage invasion or invasion of the pre-epiglottic com-
artment, protein p53 expression, HPV 16 infection and a very good
linical response to induction chemotherapy) [1–8]. This low rate
ould possibly be explained by the fact that, as they did not really
ave laryngeal cancer, the majority of otorhinolaryngologists who
nswered this questionnaire did not feel directly affected, but one
lso wonders whether all otorhinolaryngologists are really familiar
ith these data.
The ﬁrst striking result of this study is that 42.3% of otorhino-
aryngologists would not consider the slightest survival trade-off
o preserve their larynx. Other important results are the low per-
entage of otorhinolaryngologists (4.2%) who would consider a
00% trade-off to preserve their larynx and the very broad distribu-
ion (5-100) of the percentage trade-off that otorhinolaryngologists
ould consider in favour of an organ preservation protocol to
void total laryngectomy, with a median of 15%. In a prospective
tudy with a similar design, conducted in our department on a
ohort of outpatients [14], 28.6% of subjects would not consider
he slightest trade-off to preserve their larynx and the median
ercentage of survival that subjects would consider trading off
o preserve their larynx was 33%. Comparison of these two stud-
es indicates that otorhinolaryngologists are less inclined than
heir patients to trade-off survival to preserve their larynx. Fur-
hermore, the rates obtained in our study are not in agreement
ith data published by Demez and Moreau [21] as to the treat-
ent options that otorhinolaryngologists would consider for their
ancer patients. In this questionnaire-based study conducted on
 cohort of 500 otorhinolaryngologists, 75% of these specialists
hought that it was justiﬁed not to perform curative treatment if
his treatment induced an alteration of quality of life. These ﬁnd-
ngs raise the question of a possible marked disparity, in the context
f head and neck tumours, between what otorhinolaryngologists
ropose for their patients and what they would consider if theylogy, Head and Neck diseases 131 (2014) 339–343
were personally affected by the same disease. These data raise the
following philosophical question: “Would I propose to my  patient
a therapeutic procedure that I would refuse for myself?”. This
subject of debate, with a highly ethical connotation, has already
been raised by Huy [22], who, in a letter to the editor devoted
to the treatment of acoustic neuroma published in The Lancet in
1998, emphasized that the choice of treatment (gamma  knife) con-
sidered by the majority of otorhinolaryngologists if they had an
acoustic neuroma was not in agreement with the standard clin-
ical practice at the time (surgical resection) still predominantly
recommended to patients by the same practitioners. Our study
does not provide an answer to this question, but reveals that
two variables have a statistically signiﬁcant impact on the results
obtained.
The ﬁrst variable that inﬂuenced the treatment decision con-
sidered by otorhinolaryngologists when placed in a situation of
advanced stage laryngeal cancer is participation in a head and neck
cancer multidisciplinary consultation meeting. The percentage of
otorhinolaryngologists in the present study who  would not con-
sider the slightest trade-off to preserve their larynx increased from
29.3% in the absence of regular participation in multidisciplinary
consultation meetings to 49.5% when otorhinolaryngologists reg-
ularly attended such meetings (P = 0.01). The median percentage
trade-off that otorhinolaryngologists were prepared to accept to
preserve their larynx ranged from 20% in the absence of partic-
ipation in multidisciplinary consultation meetings to 10% when
otorhinolaryngologists participated in such meetings (P = 0.004).
Otorhinolaryngologists faced with a hypothetical situation of
advanced stage laryngeal cancer who  regularly participated in head
and neck cancer multidisciplinary consultation meetings there-
fore appeared to prefer total laryngectomy rather than a larynx
preservation protocol. This result could be explained by the fact
that otorhinolaryngologists who  participate in these multidisci-
plinary consultation meetings are very familiar with laryngeal
preservation for advanced stage laryngeal cancer and are very
well informed about the considerable complication and failure
rates, the difﬁculties encountered to treat these complications and
their consequences and failures in terms of survival and quality
of life.
The second variable that inﬂuenced the treatment decision con-
sidered by otorhinolaryngologists placed in a hypothetical situation
of advanced stage laryngeal cancer is the number of years of prac-
tice. In the group of 94 otorhinolaryngologists who  would consider
a trade-off to preserve their larynx, this percentage increased reg-
ularly with the otorhinolaryngologist’s age (Fig. 2, P = 0, 025) and
the number of years of practice (Fig. 3; P = 0.03). Function there-
fore appears to take precedence over survival with increasing age
of otorhinolaryngologists. This is an interesting point, as multidis-
ciplinary consultation meetings are generally chaired by the most
senior specialist.
5. Conclusion
This prospective study demonstrates that laryngeal preser-
vation is not the primary treatment objective shared by all
otorhinolaryngologists placed in a hypothetical situation of
advanced stage laryngeal cancer. It shows that regular participation
in multidisciplinary consultation meetings and the otorhino-
laryngologist’s age signiﬁcantly inﬂuence the treatment decision
considered. The authors hope that this study will encourageto improve the medical information delivered to patients with
advanced stage laryngeal cancer. A complementary study analysing
and comparing two cohorts of otorhinolaryngologists and radio-
therapists is currently underway.
aryngo
D
c
A
f
R
[
[
[
[
[
[
[
[
[
[
[O. Laccourreye et al. / European Annals of Otorhinol
isclosure of interest
The authors declare that they have no conﬂicts of interest con-
erning this article.
cknowledgements
The authors would like to thank the Progress 2000 Association
or its technical support of this study.
eferences
[1] The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction
chemotherapy plus radiation compared with surgery in patients with advanced
laryngeal cancer. N Engl J Med  1991;324:685–90.
[2] Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional
treatment for head and neck squamous cell carcinoma: three metaanaly-
sis  of updated individual data. MACH-C collaborative group. Metaanalysis of
chemotherapy on head and neck cancer. Lancet 2000;355:949–55.
[3] Forastiere AA, Goepfert H, Maor M,  et al. Concurrent chemotherapy and radio-
therapy for organ preservation in advanced laryngeal cancer. N Engl J Med
2003;34:2091–8.
[4] Forastiere AA, Maor M,  Weber RS, et al. Long-term results of Intergroup RTOG
91-11: a phase III trial to preserve the larynx – induction cisplatin/5-FU and
radiation therapy versus concurrent cisplatin and radiation therapy versus
radiation therapy. J Clin Oncol 2006;24(18S):5517.
[5] Pﬁster DG, Laurie SA, Mendenhall WM,  et al. American Society of Clinical Oncol-
ogy Clinical Practice Guidelines for the use of larynx-preservation strategies in
the treatment of laryngeal cancer. J Clin Oncol 2006;22:1–12.
[6] Chen AY, Halpern M.  Factors predictive of survival in advanced laryngeal cancer.
Arch Otolaryngol Head Neck Surg 2007;133:1270–6.
[7] Pignon JP, Le Maitre A, Maillard E, et al. Meta-analysis of chemotherapy in
head and neck cancer (MACH-NC): an update of 93 randomised trials and
17,346 patients. Radiother Oncol 2009;92:4–14.
[8] Blanchard P, Baujat B, Holostencko V, et al. Meta analysis of chemotherapy in
head and neck cancer (MACH-NC): a comprehensive analysis by tumour site.
Radiother Oncol 2011;100:33–40.
[
[logy, Head and Neck diseases 131 (2014) 339–343 343
[9] Loi n◦ 2002-203 du 4 mars 2002. Journal Ofﬁciel de la République Franc¸ aise 5
mars 2002:4118–58.
10] McNeil BJ, Weichselbaum R, Pauker SG. Speech and survival. Trade-offs
between quality and quantity of life in laryngeal cancer. N Engl J Med
1981;2:982–7.
11] Laccourreye O, Malinvaud D, Holsinger FC, et al. Trade-off between survival
and laryngeal preservation in advanced laryngeal cancer: the otorhino-
laryngology patient’s perspective. Ann Otol Rhinol Laryngol 2012;121:
570–5.
12] Plante DA, Piccirillo JF, Sofferman RA. Decision analysis of treatment options in
pyriform sinus carcinoma. Med  Decis Making 1987;7:74–83.
13] van der Donk J, Levendag PC, Kuijpers AJ, et al. Patient participation in clinical
decision-making for treatment of T3 laryngeal cancer: a comparison of state
and process utilities. J Clin Oncol 1995;13:2369–78.
14] Laccourreye O, Malinvaud D, Consoli SM,  et al. Souhait et impact de
l’information avant laryngectomie totale ou préservation laryngée dans les can-
cers du larynx de stade avancé. Eur Ann Otorhinolaryngol Head Neck Dis 2013
[sous presse].
15] Smitt MC, Heltzel M.  Women’s use of resources in decision-making for early-
stage breast cancer: results of a community-based survey. Ann Surg Oncol
1997;4:564–9.
16] Temple WJ,  Russell ML, Parsons LL, et al. Conservation surgery for breast
cancer as the preferred choice: a prospective analysis. J Clin Oncol 2006;24:
3367–73.
17] Molenaar S, Oort F, Sprangers M,  et al. Predictors of patients’ choices for
breast-conserving therapy or mastectomy: a prospective study. Br J Cancer
2004;90:2123–30.
18] Diefenbach MA, Dorsey J, Uzzo RG, et al. Decision-making strategies for patients
with localized prostate cancer. Semin Urol Oncol 2002;20:55–62.
19] Song L, Chen RC, Bensen JT, et al. Who  makes the decision regarding
the treatment of clinically localized prostate cancer-the patient or physi-
cian? Results from a population-based study. Cancer 2013;119(2):421–8,
http://dx.doi.org/10.1002/cncr.27738 [Epub 2012 Jul 11].
20] Foote RL, Brown PD, Garces YI, et al. Informed consent in advanced laryngeal
cancer. Head Neck 2007;29:230–5.21] Demez PH, Moreau PR. Perception of head and neck cancer quality of
life  within the medical world: a multicultural study. Head Neck 2009;31:
1056–67.
22] Huy PT. Operating on intracanalicular acoustic neuroma – what would ENT
doctors choose for themselves? Lancet 1998;351:1406.
